Stay updated on IBI310 Combo vs Sorafenib in HCC Clinical Trial
Sign up to get notified when there's something new on the IBI310 Combo vs Sorafenib in HCC Clinical Trial page.

Latest updates to the IBI310 Combo vs Sorafenib in HCC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe study record history now includes a new revision entry v3.6.6 and removes the previous v3.6.5, reflecting an update to the official history log.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedA new revision entry v3.6.5 was added to the Record History and the previous v3.6.4 entry was removed, reflecting a version update to the study record.SummaryDifference0.1%

- Check45 days agoChange DetectedThe study record history now shows a new release entry, Revision: v3.6.4, replacing the prior Revision: v3.6.3. This is a non-content update to the page's revision history.SummaryDifference0.1%

- Check66 days agoChange DetectedThe record history now includes the new release revision v3.6.3, replacing the previous v3.6.2. This reflects a software update to the ClinicalTrials.gov interface rather than changes to study data.SummaryDifference0.1%

- Check73 days agoChange DetectedRecord History now shows a new revision entry for v3.6.2, replacing the previous v3.6.0 in the version list.SummaryDifference0.1%

- Check87 days agoChange DetectedRecruitment status updated to no longer looking for participants. The history now includes a new revision entry (v3.6.0) to document this update.SummaryDifference0.4%

Stay in the know with updates to IBI310 Combo vs Sorafenib in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBI310 Combo vs Sorafenib in HCC Clinical Trial page.